Previous close | 0.7200 |
Open | 0.7300 |
Bid | 0.0600 |
Ask | 0.8700 |
Strike | 370.00 |
Expiry date | 2024-10-18 |
Day's range | 0.6900 - 0.7400 |
Contract range | N/A |
Volume | |
Open interest | 60 |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
The Danish pharmaceutical giant, which became Europe’s most valuable company last year, said Wegovy sales jumped 106% in the first quarter.
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]